Biotech's torrid run may not be over, analyst says
May 01, 2015 at 15:40 PM EDT
Biotech's "great run" will continue despite a bumpy April, which came on the heels of a big jump in the sector, one analyst said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.